Skip to content
Back to Blog

Secondaries and Founder Liquidity: How to Sell Some Equity Before IPO

Founder secondaries are now a normal part of growth rounds — more than $100B in private secondary volume traded in 2024, and most large growth funds actively buy secondary stakes alongside primary checks — but the structure, timing, and tax implications determine whether a secondary adds financial security or destroys investor confidence. The average time from founding to IPO is now ~10 years, meaning paper net worth accumulates for a decade without a bank balance to match. This post explains how founder secondaries actually work, what investors will and won’t accept, and the QSBS tax trap that costs founders seven figures.

Why secondaries became normal

The average time from founding to IPO is now ~10 years, up from ~7 a decade ago. The secondary market grew accordingly: more than $100B in private secondary volume traded in 2024, and the market is still expanding. Most large growth and late-stage funds now actively buy secondary stakes alongside primary checks — it’s no longer a sign of distress, it’s a standard part of round construction.

How founder secondaries work

At a priced round — typically Series B and later — the new investor agrees to put $X into the company as a primary investment, plus $Y to buy existing shares from founders and early employees at the same price per share. Typical founder secondary: 5–15% of the total round size, capped per individual founder, and almost always conditional on the founder signing a new 2–4 year vesting schedule tied to continued employment. Walking away right after a secondary is not an option any serious investor will allow.

What investors will actually accept

A few rules of thumb in the current market:

  • Founders can usually take some chips off the table starting at Series B. At Series C and beyond, it’s expected.
  • Total founder secondary is rarely above 10–15% of the round in a single transaction. Larger amounts require a dedicated tender offer process.
  • Boards tend to approve it when the founder’s remaining ownership is still healthy — typically 20%+ post-secondary — and when the founder has been building for 4+ years.
  • Early employees with meaningful vesting increasingly get a small allocation in the same tender, which helps retention at a critical growth stage.
  • Lead investors sometimes structure the secondary at a small discount (5–10%) to the primary price as compensation for providing liquidity.

The hidden risks

  • Tax treatment varies significantly by jurisdiction. In the US, selling shares that qualify as QSBS before the 5-year holding period voids the exclusion — a mistake that can cost 7-figures in unnecessary capital gains tax. Plan the timing with a tax advisor before you negotiate the secondary.
  • Optics matter. A founder who tries to take 30% off the table at Series B signals “I’m not fully committed to this outcome.” Investors will price that perception in or walk away from the round entirely.
  • Secondary buyers — particularly dedicated secondary funds rather than lead investors — often demand information rights, pro-rata rights in future rounds, and board observer seats that surprise founders years later. Read the shareholder agreement carefully.

What this means for you

If you’re post-Series B, secondaries should be a planned conversation at your next round, not an emergency one when you’re cash-stressed. The right time to negotiate them is when you have leverage — at the close of a competitive round, not between rounds when you need the money. The right amount is enough to remove meaningful personal financial stress — not enough to signal you’ve mentally moved on.

Frequently Asked Questions

Q: How much can a founder realistically take in a secondary at Series B? A: At Series B, founder secondary transactions typically represent 5–15% of the total round size — so on a $30M Series B, a founder might sell $1.5M–$4.5M of personal shares. Boards generally approve it when the selling founder retains at least 20% post-transaction and commits to a new 2–4 year vesting schedule.

Q: Does selling shares in a secondary affect QSBS eligibility? A: Yes — selling QSBS-qualified shares before a 5-year holding period voids the federal capital gains exclusion entirely for the shares sold. A founder who sells $2M of shares at Series B in year 3 loses the QSBS exclusion on those specific shares, creating a capital gains tax bill of $400k–$600k that could have been zero with one more year of holding. Work with a tax advisor before agreeing to any secondary terms.

Q: When do secondary funds buy founder equity and what do they want in return? A: Dedicated secondary funds typically purchase founder equity between Series C and pre-IPO at a 5–20% discount to the latest primary round price. In exchange, they typically require information rights, pro-rata participation rights in future rounds, and sometimes a board observer seat — rights that become permanent features of the cap table and can complicate future governance.

Q: What is a tender offer and when is it used instead of a direct secondary? A: A tender offer is a structured process where the company or a lead investor makes a formal offer to buy shares from multiple employees and shareholders simultaneously, typically with a 20–30 day window for acceptance. It is used when secondary volume exceeds 15–20% of the round size, or when the company wants to provide liquidity to a broad group including early employees and angels — not just founders.

Q: How does a founder secondary affect the Series C fundraising process? A: Modest secondaries (under 10% of round) executed at Series B rarely affect Series C fundraising if the founder retains strong ownership and re-commits via a new vesting schedule. Large secondaries or repeated transactions — especially those at a discount to round price — signal reduced founder conviction to incoming Series C investors and can reduce both valuation and terms quality in the next round.

CTA: Calculate inside CrackTheDeck how much you can realistically take through a secondary at your next round — without giving up control or signalling weakness to incoming investors.